Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$1.14 - $1.95 $50,498 - $86,379
-44,297 Reduced 35.04%
82,135 $152,000
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $91,405 - $166,814
76,171 Added 151.55%
126,432 $168,000
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $35,367 - $76,376
21,698 Added 75.97%
50,261 $84,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $20,850 - $106,825
28,563 New
28,563 $15,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.